295 related articles for article (PubMed ID: 25921124)
1. Ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes.
Yang Q; Liu HY; Liu D; Song YQ
Asian Pac J Cancer Prev; 2015; 16(8):3229-32. PubMed ID: 25921124
[TBL] [Abstract][Full Text] [Related]
2. Mammographic and ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes.
Kim MY; Choi N
Acta Radiol; 2013 Oct; 54(8):889-94. PubMed ID: 23761558
[TBL] [Abstract][Full Text] [Related]
3. The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases.
Wojcinski S; Stefanidou N; Hillemanns P; Degenhardt F
BMC Womens Health; 2013 Nov; 13():47. PubMed ID: 24252758
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
[TBL] [Abstract][Full Text] [Related]
5. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study.
Li CY; Zhang S; Zhang XB; Wang P; Hou GF; Zhang J
Asian Pac J Cancer Prev; 2013; 14(6):3779-84. PubMed ID: 23886182
[TBL] [Abstract][Full Text] [Related]
7. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
[TBL] [Abstract][Full Text] [Related]
8. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
10. Associations between mammography and ultrasound imaging features and molecular characteristics of triple-negative breast cancer.
Li B; Zhao X; Dai SC; Cheng W
Asian Pac J Cancer Prev; 2014; 15(8):3555-9. PubMed ID: 24870756
[TBL] [Abstract][Full Text] [Related]
11. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.
Doval DC; Sharma A; Sinha R; Kumar K; Dewan AK; Chaturvedi H; Batra U; Talwar V; Gupta SK; Singh S; Bhole V; Mehta A
Asian Pac J Cancer Prev; 2015; 16(12):4959-64. PubMed ID: 26163622
[TBL] [Abstract][Full Text] [Related]
13. Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature.
Li JW; Zhang K; Shi ZT; Zhang X; Xie J; Liu JY; Chang C
Sci Rep; 2018 Jun; 8(1):9040. PubMed ID: 29899425
[TBL] [Abstract][Full Text] [Related]
14. Radiological features of triple-negative breast cancers (73 cases).
Boisserie-Lacroix M; Mac Grogan G; Debled M; Ferron S; Asad-Syed M; Brouste V; Mathoulin-Pelissier S; Hurtevent-Labrot G
Diagn Interv Imaging; 2012 Mar; 93(3):183-90. PubMed ID: 22421282
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and demographic evaluation of triple- negative breast cancer patients among a turkish patient population: a single center experience.
Somali I; Ustaoglu BY; Tarhan MO; Yigit SC; Demir L; Ellidokuz H; Erten C; Alacacioglu A
Asian Pac J Cancer Prev; 2013; 14(10):6013-7. PubMed ID: 24289617
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes.
Murphy BL; Day CN; Hoskin TL; Habermann EB; Boughey JC
Ann Surg Oncol; 2018 Aug; 25(8):2241-2248. PubMed ID: 29786125
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided evaluation of the correlation between MRI morphology and immunohistochemical biomarkers or molecular subtypes in breast cancer.
Jiang S; Hong YJ; Zhang F; Li YK
Sci Rep; 2017 Oct; 7(1):13818. PubMed ID: 29062076
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype.
McGhan LJ; McCullough AE; Protheroe CA; Dueck AC; Lee JJ; Nunez-Nateras R; Castle EP; Gray RJ; Wasif N; Goetz MP; Hawse JR; Henry TJ; Barrett MT; Cunliffe HE; Pockaj BA
Ann Surg Oncol; 2014 Feb; 21(2):361-7. PubMed ID: 24046116
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
Choi JE; Kang SH; Lee SJ; Bae YK
Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of a color map pattern on shear-wave elastography for invasive breast cancer.
Lee S; Jung Y; Bae Y
Surg Oncol; 2016 Mar; 25(1):44-8. PubMed ID: 26979640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
